Hodogaya Chemical Co., Ltd. (JP:4112)
:4112
Want to see JP:4112 full AI Analyst Report?
Top Page
Hodogaya Chemical Co., Ltd.
(4112)
Select Model
Select Model
Rating:72Outperform
Price Target:
¥2,388.00
▼(-6.50% Downside)
Action:Upgraded
Date:05/17/26
The score is driven primarily by solid overall financials with conservative leverage, offset by inconsistent cash flow and recent margin compression. Technicals add meaningful support given strong price trend above key moving averages and positive momentum indicators. Valuation is supportive with a moderate P/E and dividend yield.
Positive Factors
Conservative balance sheet
Low leverage and steady equity growth give the company durable financial flexibility. A conservative capital structure reduces refinancing and interest-rate risk, enabling sustained investment in plants or R&D and cushioning cyclical downturns for at least the next several quarters.
Negative Factors
Volatile cash generation
Inconsistent conversion of profits into cash and repeated negative free cash flow reduces predictability for capital allocation. Lumpy working capital and capex timing can constrain dividend sustainability, deleverage plans, and limit funding for strategic investments over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and steady equity growth give the company durable financial flexibility. A conservative capital structure reduces refinancing and interest-rate risk, enabling sustained investment in plants or R&D and cushioning cyclical downturns for at least the next several quarters.
Read all positive factors
Hodogaya Chemical Co., Ltd. (4112) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥35.10B
Dividend Yield2.37%
Average Volume (3M)79.15K
Price to Earnings (P/E)12.9
Beta (1Y)1.21
Revenue Growth-1.11%
EPS Growth-3.98%
CountryJP
Employees922
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)192.05
Shares Outstanding16,827,452
10 Day Avg. Volume72,200
30 Day Avg. Volume79,146
Financial Highlights & Ratios
PEG Ratio-3.26
Price to Book (P/B)0.75
Price to Sales (P/S)0.82
P/FCF Ratio-155.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)106.9
Revenue Forecast (FY)¥49.60B
Hodogaya Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Hodogaya Chemical Co., Ltd. manufactures and sells functional colorants, specialty polymers, basic chemicals, and agro-science products in Japan. Its Functional Colorants segment offers OLED materials that are used in smartphone display panels, ta...
How the Company Makes Money
Hodogaya Chemical makes money primarily by manufacturing and selling chemical products and functional materials to other businesses (B2B). Revenue is generated when the company supplies its products—typically produced in-house from chemical feedst...
Hodogaya Chemical Co., Ltd. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 48.04B | 48.58B | 44.26B | 43.32B | 41.88B |
| Gross Profit | 18.38B | 18.91B | 16.87B | 16.50B | 17.50B |
| EBITDA | 7.13B | 7.89B | 6.35B | 5.64B | 8.09B |
| Net Income | 3.05B | 3.18B | 2.48B | 2.22B | 3.25B |
Balance Sheet | |||||
| Total Assets | 86.41B | 79.86B | 81.16B | 72.05B | 66.45B |
| Cash, Cash Equivalents and Short-Term Investments | 10.14B | 10.77B | 12.96B | 10.49B | 11.45B |
| Total Debt | 9.49B | 8.79B | 9.81B | 11.08B | 7.02B |
| Total Liabilities | 22.79B | 21.32B | 23.71B | 22.15B | 18.53B |
| Stockholders Equity | 52.58B | 48.60B | 47.73B | 42.84B | 41.42B |
Cash Flow | |||||
| Free Cash Flow | -254.00M | 248.00M | 2.99B | -2.06B | 4.38B |
| Operating Cash Flow | 6.09B | 5.67B | 8.34B | 1.06B | 6.14B |
| Investing Cash Flow | -5.03B | -6.55B | -3.95B | -7.04B | -3.57B |
| Financing Cash Flow | -694.00M | -1.88B | -2.07B | 2.29B | -1.85B |
Hodogaya Chemical Co., Ltd. Technical Analysis
Negative
2554.00
Price Trends
2358.51
Negative
2306.28
Negative
2001.08
Positive
Market Momentum
-4.40
Positive
35.22
Neutral
13.08
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4112, the sentiment is Negative. The current price of 2554 is above the 20-day moving average (MA) of 2395.40, above the 50-day MA of 2358.51, and above the 200-day MA of 2001.08, indicating a neutral trend. The MACD of -4.40 indicates Positive momentum. The RSI at 35.22 is Neutral, neither overbought nor oversold. The STOCH value of 13.08 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4112.
Hodogaya Chemical Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥35.10B | 12.94 | ― | 2.37% | -1.11% | -3.98% | |
72 Outperform | ¥34.12B | 9.56 | ― | 1.90% | -0.76% | 25.33% | |
69 Neutral | ¥54.76B | 13.50 | ― | 2.92% | -5.24% | 17.53% | |
65 Neutral | ¥51.85B | 19.62 | ― | 4.37% | -3.84% | -43.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥42.11B | -44.17 | ― | 3.24% | 2.94% | -136.46% | |
52 Neutral | ¥34.62B | 20.68 | ― | 3.70% | 29.30% | -82.16% |
* Basic Materials Sector Average
JP:4112
Hodogaya Chemical Co., Ltd.
2,149.00
716.32
50.00%
JP:4027
Tayca Corporation
1,970.00
761.60
63.03%
JP:4078
Sakai Chemical Industry Co., Ltd.
3,270.00
831.22
34.08%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,467.00
418.62
20.44%
JP:4462
Ishihara Chemical Company,Ltd.
2,351.00
435.19
22.72%
JP:4611
Dai Nippon Toryo Company, Limited
1,222.00
107.11
9.61%
Hodogaya Chemical Co., Ltd. Corporate Events
Hodogaya Chemical Launches “CODE/CHORD 2030” After Missing Previous Profit Targets
May 15, 2026
Hodogaya Chemical has unveiled a new five-year medium-term management plan, “CODE/CHORD 2030,” after falling short of all key targets in its previous plan, particularly due to weaker-than-expected monetization in its OLED materials bus...
Hodogaya Chemical to Renew and Tighten Takeover Defense Plan
May 15, 2026
Hodogaya Chemical has resolved to continue its takeover response policy, a set of countermeasures against large-scale share purchases, with partial amendments designed to better safeguard corporate value and shareholder interests. The revised plan...
Hodogaya Chemical Outlines FY2025 Results and FY2026 Forecasts
May 15, 2026
Hodogaya Chemical Co., Ltd. released an outline of its consolidated financial results for fiscal year 2025, ended March 2026, along with a breakdown of performance by business segment. The company also presented its financial and dividend forecast...
Hodogaya Chemical Posts Lower Profit, Warns of Sharper Earnings Drop Despite Sales Growth Outlook
May 15, 2026
Hodogaya Chemical reported fiscal 2026 consolidated net sales of ¥48.0 billion, down 1.1% year on year, with operating profit dropping 23.9% to ¥3.7 billion and profit attributable to owners of parent slipping 3.9% to ¥3.1 billion, ...
Hodogaya Chemical Lifts Full-Year Profit Forecast on Cost Cuts and FX Gains
Apr 27, 2026
Hodogaya Chemical Co., Ltd. has revised upward its consolidated forecast for the fiscal year ending March 31, 2026, expecting higher net sales, operating profit, ordinary profit, and profit attributable to owners compared with its previous project...
Hodogaya Chemical to Acquire Hungary’s Framochem in Push for Global Specialty Chemicals Growth
Mar 27, 2026
Hodogaya Chemical will acquire 100% of Hungarian firm Framochem Francia-Magyar Finomkemiai Kft, making it a wholly owned subsidiary as part of its new medium-term management plan to expand its Specialty Chemicals business. Framochem, founded in 19...
Hodogaya Chemical Buys Stake in YUKI GOSEI KOGYO to Drive Nucleic Acid CDMO Push
Feb 26, 2026
Hodogaya Chemical has agreed to collaborate with YUKI GOSEI KOGYO in the nucleic acid therapeutics contract development and manufacturing business, combining Hodogaya’s non-GMP oligonucleotide capabilities with YGK’s GMP-compliant manu...
Hodogaya Chemical Expands Employee Stock Ownership Plan to Entire Group
Feb 24, 2026
Hodogaya Chemical Co., Ltd. will extend its Japanese Employee Stock Ownership Plan to all employees of the company and its domestic consolidated subsidiaries from fiscal 2026, broadening an incentive scheme first introduced in 2023 and partially e...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.